MT2021-18: Prospective observational study of the immunogenicity of vaccines for severe acuterespiratory syndrome coronavirus 2 (sars-cov-2) after autologous hematopoietic stem cell transplantation(hct), allogeneic hct, and chimeric antigen re

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. Vaccine Immunogenicity 65%
3. Histocompatibility Antigens 59%
4. Coronavirus 58%
5. Observational Studies 36%
6. Severe Acute Respiratory Syndrome 30%
7. Prospective Studies 29%